Abstracts

Intact HIV Reservoir Levels Are Stable After Short-Term ART Interruption

Background: As HIV cure remains a high priority for HIV research, analytical treatment interruption (ATI) in clinical studies remain vital to understand mechanisms for ART-free HIV remission. However, the impact of short-term treatment interruption on the intact HIV reservoir remains unclear. Methods: We evaluated participants who underwent treatment interruption as part of the ACTG A5345…

CD4-Targeted mRNA Delivery of Tat Reverses HIV-1 Latency

Background: Interventions that reverse viral latency are needed for an HIV cure. The viral protein Tat drives HIV expression but is toxic and difficult to deliver in a targeted manner. We tested whether CD4-targeted delivery of Tat encoding mRNA could safely reverse latency. Methods: mRNA encoding wildtype and nontoxic Subtype B and D Tat variants…

Synergistic Effects of HIV, HPV, and Polyomaviruses on Interferon Response in Male Anal Mucosa

Background: Viral persistence is a crucial prerequisite for high-risk (HR) HPV-associated tumor growth, such as anal squamous cell carcinoma (SCC). Men living with HIV (MLWH) are more likely to be co-infected with HPV. Moreover, HIV may alter epithelial integrity, thereby favoring not only HPV but also Polyomaviruses (HPyVs) infections in basal cells, where they dysregulate…

Common T-Cell Features Predicting Time to Rebound in Interventional and Non-Interventional Treatment

Background: Immunological features predicting time-to-rebound during analytical treatment interruption (ATI) may differ between cohorts, and be impacted by whether or not therapeutic interventions were used. Here, we used CyTOF to identify shared and unique pre-ATI features of T cells associated with time-to-rebound in the non-interventional ACTG A5345 cohort and 3 interventional Danish cohorts. Methods: A…

Identification of Innate Lymphoid Cell Subsets in the Human Female Genital Tract That Respond to HIV

Background: Women acquire HIV mainly through sexual contact. Identification of innate immune mechanisms that protect against infection in the female genital tract (FGT) will enable strategies to prevent HIV acquisition. Innate lymphoid cells (ILCs) are tissue-resident cells specialized in cytokine secretion that provide mucosal protection against infections in mice. However, human ILCs remain poorly characterized…

Efficacy and Safety of Weekly Islatravir Plus Lenacapavir in PWH at 24 Weeks: A Phase II Study

Background: Islatravir (ISL), a nucleoside reverse transcriptase translocation inhibitor, and lenacapavir (LEN), a capsid inhibitor, have potent anti-HIV-1 activity and pharmacokinetic profiles permitting once-weekly (QW) oral dosing. We investigated efficacy and safety of ISL+LEN in virologically suppressed people with HIV-1. Methods: In this Phase 2, randomized, open-label, active-controlled study (NCT05052996), virologically suppressed adults on bictegravir/emtricitabine/tenofovir…